NCT00013624View on ClinicalTrials.gov

Riluzole to Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

March 31, 2005

Conditions
Parkinson's Disease
Interventions
DRUG

IV Levodopa

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00013624 - Riluzole to Treat Parkinson's Disease | Biotech Hunter | Biotech Hunter